Determining the true valuation and cost parameters for research-grade Follistatin requires analyzing synthesis complexity, isoform selection, and rigorous analytical verification. This guide breaks down the primary drivers of follistatine peptide prijs alongside analytical quality control standards essential for valid preclinical research.
Determining the true valuation and cost parameters for research-grade Follistatin requires analyzing synthesis complexity, isoform selection, and rigorous analytical verification. This guide breaks down the primary drivers of follistatine peptide prijs alongside analytical quality control standards essential for valid preclinical research.
De follistatine peptide prijs (Follistatin peptide price) in professional research settings is primarily governed by synthesis complexity, sequence length (such as FS-344 versus FS-315), lot-specific purity verification, and stringent endotoxin quantification. Premium research-grade Follistatin demands advanced recombinant expression or multi-step solid-phase peptide synthesis (SPPS) followed by reverse-phase high-performance liquid chromatography (RP-HPLC) to achieve analytical purities exceeding 98%. Institutional procurement decisions evaluate cost against verified mass spectrometry identity, low endotoxin thresholds, and reliable batch-to-batch consistency.
Follistatin is an endogenous autocrine monomeric glycoprotein expressed across various mammalian tissues. In preclinical literature, it functions as a potent antagonist to members of the Transforming Growth Factor-beta (TGF-β) superfamily. Structurally, Follistatin contains a high concentration of cysteine residues forming intramolecular disulfide bridges, making its synthetic replication complex.
Investigators commonly evaluate different genetic and recombinant variants. The precursor protein contains 344 amino acids (often referred to as Follistatin-344). Post-translational processing yields distinct isoforms, including the membrane-bound FS-315 variant and the circulating FS-288 variant. The differential heparin-binding affinity between these isoforms governs their localized tissue distribution in animal models.
When evaluating the *follistatine peptide prijs* across suppliers, researchers must distinguish between basic truncated synthetic fragments and full-length recombinant proteins. Full-length recombinant variants require eukaryotic expression systems to preserve authentic folding patterns and disulfide linkages, which naturally elevates synthesis costs compared to basic short-chain linear peptides.
The primary mechanism of action investigated in laboratory assays involves Follistatin's high-affinity binding to Myostatin (Growth Differentiation Factor 8, or GDF-8) and Activin A. Preclinical studies suggest that Follistatin sequesters Myostatin, preventing it from binding to the Activin type IIB receptor (ActRIIB) complex on target cellular membranes.
By neutralizing Activin A and Myostatin, Follistatin suppresses downstream Smad2/3 signaling cascades. In vitro assays demonstrate that inhibition of these intracellular signaling cascades downregulates genes responsible for muscle protein degradation, such as Atrogin-1 and MuRF1, while promoting satellite cell activation and myotube differentiation.
Because of its broad affinity within the TGF-β superfamily, researchers utilize high-purity research peptides targeting this pathway to explore cellular hypertrophy, muscular dystrophy models, and fibrotic tissue remodeling. Investigating these regulatory cascades requires highly pure compounds to prevent off-target cell culture artifacts caused by contaminants or degraded protein fragments.
Extensive preclinical investigation has documented the physiological effects of Follistatin administration in laboratory models. Rodent models carrying transgenic modifications or receiving viral vector-mediated Follistatin expression exhibited marked increases in skeletal muscle mass, fiber cross-sectional area, and overall force generation without adverse cardiac tissue proliferation.
In vitro data indicate that culturing primary skeletal muscle cells with recombinant Follistatin blunts the inhibitory effects of exogenous Myostatin on protein synthesis. Further preclinical studies suggest potential applications in researching metabolic regulation, as Myostatin inhibition has been linked to altered glucose homeostasis and reduced adipose tissue accumulation in high-fat diet rodent models.
Ongoing exploratory research also examines Follistatin's role in tissue repair and anti-fibrotic signaling. By binding Activin A, Follistatin reduces excessive extracellular matrix deposition in preclinical models of hepatic, pulmonary, and renal fibrosis, making it a critical focus area in cell biology laboratories.
When comparing the *follistatine peptide prijs* across chemical vendors, laboratory managers must audit the specific analytical guarantees provided. The pricing structure of research-grade Follistatin relies on several critical quality assurance elements:
1. **Synthesis Expression System**: Eukaryotic expression (e.g., CHO or yeast expression systems) ensures native glycosylation and correct tertiary structure, whereas prokaryotic systems may yield misfolded proteins requiring costly refolding procedures.
2. **Purity Verification (RP-HPLC)**: Achieving ≥98% purity via high-performance liquid chromatography eliminates micro-impurities, incomplete sequences, and organic solvents that can disrupt delicate cell culture media.
3. **Identity Confirmation (ESI-MS)**: Mass spectrometry confirms exact molecular weight and verifies structural sequence accuracy against standard theoretical mass.
4. **Endotoxin Testing**: Low-endotoxin processing (<0.01 EU/µg) is essential for cell line viability and animal study validity, as bacterial lipopolysaccharides (LPS) induce confounding inflammatory responses.
5. **Batch Traceability**: Complete lot-specific documentation ensures reproducible results across longitudinal research trials.
Research laboratories investigating myostatin inhibition often compare Follistatin to alternative regulatory molecules within the TGF-β axis. Understanding the mechanistic differences helps researchers select the appropriate compound for their specific experimental design.
While Follistatin-344 acts as a direct ligand trap for both Myostatin and Activins, soluble receptor fusion proteins such as ACE-031 function by mimicking the extracellular domain of the ActRIIB receptor. This broad decoy approach sequesters Myostatin alongside BMP-9 and BMP-10. Conversely, specific growth factor variants like IGF-1 DES act through distinct receptor tyrosine kinase pathways (IGF-1R) to stimulate protein synthesis via Akt/mTOR rather than Smad2/3 blockade.
Selecting between these target compounds depends on whether the laboratory model demands broad multi-ligand inhibition (Follistatin), selective receptor decoy binding (ACE-031), or direct hyperplastic pathway stimulation. Further details on these target classes are detailed in our comprehensive myostatin inhibition research guide.
To preserve protein stability and biological activity in laboratory settings, strict storage and handling protocols must be maintained. Lyophilized Follistatin should be stored at -20°C or -80°C upon arrival to prevent thermal degradation.
When preparing Follistatin for in vitro or ex vivo assays, reconstitution should be performed using sterile, bacteriostatic water or target-buffered saline (such as PBS, pH 7.4). Gentle reconstitution without vigorous vortexing prevents mechanical agitation and denaturation of complex tertiary protein structures.
Following initial reconstitution, the solution should be aliquoted into single-use working volumes using low-protein-binding microcentrifuge tubes. Repeated freeze-thaw cycles must be avoided, as phase changes degrade protein folding and significantly reduce bioactivity. Aliquots stored at -80°C maintain structural stability over extended research timelines.
Procuring research compounds without independent analytical verification introduces severe risk of experimental error, batch variability, and cell line toxicity. At PX1 Research, every production lot undergoes exhaustive quality control testing to ensure strict scientific rigor.
We manufacture our research peptides in US-based, GMP-compliant facilities and conduct third-party verification through an independent ISO 17025 accredited laboratory. Every batch of Follistatin is supplied with a lot-specific Certificate of Analysis (COA) containing raw RP-HPLC chromatograms and Electrospray Ionization Mass Spectrometry (ESI-MS) spectra.
Furthermore, our compounds undergo rigorous Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain well below standard experimental thresholds. Institutional procurement teams seeking reliable supply chains can establish a wholesale lab account to access volume pricing and batch reservation services.
What is the primary factor driving the follistatine peptide prijs difference between vendors?
The price variation is driven by synthesis method (recombinant vs. standard SPPS), achieved purity level (≥98% vs lower grades), presence of third-party COAs (RP-HPLC and MS verification), and strict endotoxin testing protocols.
What isoform of Follistatin is most frequently referenced in preclinical literature?
Follistatin-344 (FS-344) and its post-translationally processed variant FS-315 are the most widely cited isoforms in rodent models and in vitro muscle cell culture experiments.
Are PX1 Research peptides intended for human consumption or clinical use?
No. All compounds supplied by PX1 Research are strictly for laboratory research, in vitro experimentation, and preclinical scientific studies. They are not for human or animal therapeutic use.
How is Follistatin purity verified at PX1 Research?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to assess chemical purity alongside Electrospray Ionization Mass Spectrometry (ESI-MS) to verify molecular weight and identity.
What solvent should be used to reconstitute research-grade Follistatin?
For standard laboratory assays, reconstitution is typically performed using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4) under a laminar flow hood.
How should reconstituted Follistatin be stored to prevent degradation?
Reconstituted solutions should be divided into single-use aliquots using low-protein-binding tubes and frozen at -20°C or -80°C. Repeated freeze-thaw cycles should be avoided.
What are the standard endotoxin limits for PX1 Research compounds?
PX1 Research compounds undergo LAL endotoxin testing to ensure levels remain under strict research thresholds (<0.01 EU/µg), protecting cell cultures from inflammatory artifacts.
How does Follistatin differ mechanistically from ACE-031?
Follistatin is an endogenous monomeric protein that binds directly to Myostatin and Activin A, whereas ACE-031 is a fusion protein consisting of the ActRIIB receptor extracellular domain linked to an Fc antibody fragment.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.